Scerene Healthcare is backed by Aisling Capital, a leading venture capital fund with $1.6 billion under management that invests in products, technologies and global businesses that advance health. Aisling Capital is led by a group of investment professionals with diverse backgrounds in industry, science and finance. The Team’s complementary backgrounds give Aisling Capital unique perspective on the key players, events and forces shaping the life science industry, and allow the fund to identify investment opportunities. In working with its portfolio companies, the principals of Aisling Capital seek to provide the financing, relationships and guidance needed to build highly successful companies.

Steve Elms, Managing Partner, and Dov Goldstein, MD, Partner are members of the Scerene Healthcare Board of Directors.